Anticandidal Therapeutics: Discovery and Development

Antifungal agents have not seen the same level of development as other antibiotics, making it urgent to find effective treatments for Candida infections. Anticandidal Therapeutics: Discovery and Development provides comprehensive information on Candida infections and the development of anticandidal drugs. The book covers various topics such as anticandidal agents, drug transporter families, clinical studies, and drug repurposing, aiming to help researchers discover and develop novel therapies.

Format: Paperback / softback
Length: 196 pages
Publication date: 01 January 2023
Publisher: Elsevier Science Publishing Co Inc

Antifungal agents have seen a decline in development compared to other antibiotics, which have experienced significant advancements over time. The global demand for effective prophylactic and therapeutic treatments to manage the severity of infections caused by Candida remains urgent. Anticandidal Therapeutics: Discovery and Development serves as a comprehensive resource for understanding fungal human infections, particularly Candida, and the development of anticandidal drugs. This book aims to provide researchers with a foundation for discovering and developing novel anticandidal therapies. Spanning 14 chapters, Anticandidal Therapeutics offers a collective compilation of information on anticandidal agents and their discovery and development, focusing on major drug transporter families, different stages of anticandidal agent development, recent trends and progress in antifungal translational research, clinical studies status of anticandidal therapeutic agents, and drug repurposing for developing novel anticandidal agents.

Antifungal agents have seen a decline in development compared to other antibiotics, which have experienced significant advancements over time. The global demand for effective prophylactic and therapeutic treatments to manage the severity of infections caused by Candida remains urgent. Anticandidal Therapeutics: Discovery and Development serves as a comprehensive resource for understanding fungal human infections, particularly Candida, and the development of anticandidal drugs. This book aims to provide researchers with a foundation for discovering and developing novel anticandidal therapies. Spanning 14 chapters, Anticandidal Therapeutics offers a collective compilation of information on anticandidal agents and their discovery and development, focusing on major drug transporter families, different stages of anticandidal agent development, recent trends and progress in antifungal translational research, clinical studies status of anticandidal therapeutic agents, and drug repurposing for developing novel anticandidal agents.

Antifungal agents have seen a decline in development compared to other antibiotics, which have experienced significant advancements over time. The global demand for effective prophylactic and therapeutic treatments to manage the severity of infections caused by Candida remains urgent. Anticandidal Therapeutics: Discovery and Development serves as a comprehensive resource for understanding fungal human infections, particularly Candida, and the development of anticandidal drugs. This book aims to provide researchers with a foundation for discovering and developing novel anticandidal therapies. Spanning 14 chapters, Anticandidal Therapeutics offers a collective compilation of information on anticandidal agents and their discovery and development, focusing on major drug transporter families, different stages of anticandidal agent development, recent trends and progress in antifungal translational research, clinical studies status of anticandidal therapeutic agents, and drug repurposing for developing novel anticandidal agents.

Weight: 450g
Dimension: 235 x 191 (mm)
ISBN-13: 9780443187445